Elekta (OTCMKTS:EKTAY) Sees Large Volume Increase – Time to Buy?

Elekta AB (OTCMKTS:EKTAY) shares saw strong trading volume on Friday . 3,601 shares changed hands during mid-day trading, an increase of 21% from the previous session’s volume of 2,964 shares.The stock last traded at $6.10 and had previously closed at $6.10.

Elekta Stock Performance

The stock has a fifty day moving average price of $6.23 and a 200 day moving average price of $5.42. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of 86.87 and a beta of 1.06.

Elekta (OTCMKTS:EKTAY) last announced its earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a return on equity of 12.14% and a net margin of 1.62%.The firm had revenue of $427.85 million during the quarter, compared to analysts’ expectations of $436.91 million. As a group, analysts predict that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.